Compassionate Use Study of Epi-ON Corneal Collagen Crosslinking Performed Using UVA Exposure on Eyes With Ectatic Corneal Diseases for Subjects With Down Syndrome

计划入组 225 人 · 首次发布于 2025 年 8 月 21 日

Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases

计划入组 485 人 · 首次发布于 2025 年 8 月 15 日

Safety and Efficacy of Corneal Crosslinking Using the PXL-Platinum 330 for Eyes With Corneal Ectatic Conditions

计划入组 11 人 · 首次发布于 2020 年 1 月 27 日

Allogeneic corneal endothelial cell therapy (Aurion Biotech)

CytoCor

Corneal Regeneration(Omega Therapeutics)

CORNEAL CONSULTANTS OF INDIANA, P.C.

United States

Rare Disease Research, LLC

CASTLEMAN DISEASE COLLABORATIVE NETWORK

United States

FDA Grants Fast Track Designation to Epion's EpiSmart Cross-Linking System for Keratoconus Treatment

Mobile Vision Pod Innovation Accelerates Corneal Disease Clinical Trial Progress

FDA Grants IDE Approval for First Synthetic Corneal Endothelial Layer to Treat Chronic Corneal Edema